ArticleMaterials (Basel, Switzerland)2022
Glassy Carbon Modified with Cationic Surfactant (GCE/CTAB) as Electrode Material for Fast and Simple Analysis of the Arsenic Drug Roxarsone.
Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 7 citations in OpenAlex.
- Diclofenac-Impregnated Mesoporous Carbon-Based Electrode Material for the Analysis of the Arsenic Drug Roxarsone.Materials (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
For the fast and simple sensing of the arsenic drug roxarsone (ROX), the development of a glassy carbon electrode (GCE) modified with cationic surfactant (cetyltrimethylammonium bromide, CTAB) material is critical. The CTAB-modified glassy carbon electrode, in contrast to the unmodified one, showed excellent behavior for electrochemical reduction of ROX using cyclic voltammetry (CV) and square-wave adsorptive stripping voltammetry (SWAdSV) techniques. CV studies reveal an irreversible reduction process of NO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.